Wednesday

27th Sep 2023

Opinion

We need a vaccine-patent waiver. Why is the EU blocking it?

  • More than 90 percent of the population in the world's poorest countries will go without a vaccine in 2021 (Photo: imf.org)

This week, the European Parliament will vote on the Digital Green Certificate regulation.

The text proposed by the European Commission raises a number of concerns in terms of data protection, data security, and possible discrimination in its use and implementation.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • A prototype vaccine 'passport'. Linking rights and health status is a slippery slope (Photo: European Commission)

These are key issues for the Left: linking rights and health status is a slippery slope.

Some Europeans might be able to travel freely within the EU this summer but, if we want to tackle the problem at its roots, we need to lift patents on Covid-19 vaccines.

Notwithstanding the tremendous subsidies - over $12bn [€9.96bn] - offered to private companies, we will still be facing a severe shortage of vaccines.

Globally, access to Covid-19 vaccines remains worryingly low: today, less than three percent of the world population has been vaccinated and 90 percent of the population in the world's poorest countries will go without a vaccine this year.

Also, many Europeans won't be able to get this season's most sought-after jab.

The current intellectual property rights architecture leaves all the power to expand production with patent holders.

The monopoly granted to Big Pharma has enabled them to resist any kind of international attempt to share scientific data and technology, making it impossible for other manufacturers across the world to enter into production.

It's up to the companies to decide whether to enter into licensing or manufacturing agreements with other firms. This likely explains why we are currently using only 43% of global production capacity.

The only way to ramp up vaccine production, as soon as possible, is to lift patents and transfer technology. Big Pharma's arguments to keep the monopoly of intellectual property rights on vaccines have already fallen flat. So, what's the way forward from here?

The commission must support the request from South Africa and India, together with over 100 other countries, to temporarily waive TRIPS, the treaty regulating intellectual property rights at the World Trade Organization level, for Covid-19 vaccines.

The sharing of knowledge and technology will ensure more vaccines are produced as soon as possible, for everybody, everywhere across the globe.

This is not some idealist dream, it is an urgent necessity, both pragmatic and practical, supported by over 175 former heads of state and Nobel Laureates.

For half a morning, it was also endorsed by the HR/VP Josep Borrell, but then his tweet was deleted.

Over 150,000 European citizens are demanding action. We are now counting on the support of our colleagues at the European Parliament.

At the initiative of The Left, parliament has already called on the commission and member states to overcome the barriers and restrictions arising from patents and intellectual property rights in order to ensure widespread production of vaccines and their timely distribution to everyone, everywhere.

This is why The Left is demanding a debate on the TRIPS waiver in plenary and has tabled some proposals in reaction to the commission's Digital Green Certificate Regulation. We need to make sure that the vaccine against Covid-19 becomes a global common good.

If the EU wants to shake off the longstanding criticism of being "too slow, too disunited, too disconnected from the people" and doing 'too little, too late', now is the time to act.

Brussels can lead the international community out of the crisis of the century by placing the right to health where it belongs: at the centre of its decisions and politics.

Author bio

Marc Botenga, Katerina Konecna and Dimitrios Papadimoulis are all MEPs with The Left.

Disclaimer

The views expressed in this opinion piece are the author's, not those of EUobserver.

'Shocking' disparities bolster vaccine patent-waiver call

The unbalanced distribution of vaccines globally has triggered calls to waive intellectual property rights for Covid-19 vaccines. But an analysis of lobbying by watchdog Corporate Europe Observatory revealed how Big Pharma has influenced the EU Commission's position.

MEPs raise concerns on vaccine 'travel certificates'

While most MEPs have been vocal in support of the proposal by the European Commission for EU-wide vaccine certificates, key questions remain - ranging from fundamental rights, to its scientific validity.

EU now 'open' to vaccine waiver, after Biden U-turn

The European Union is now ready to discuss the proposal to waive temporarily intellectual property rights for Covid-19 vaccines - following the historic decision by Washington in favour of easing patent rules.

Ramaphosa slams EU for protecting vaccine profits

African leaders, after their two-day summit in Brussels, called an offer by the EU to help Africa build vaccine-manufacturing plants was incomplete without backing a vaccine patent-waiver proposal.

Pressure builds on EU to back WTO vaccine-patent waiver

MEPs have backed a motion demanding the temporality lifting of intellectual properties rights of Covid-19 vaccines - a symbolic move that puts pressure on the European Commission to change its position on the issue of global access to vaccines.

Column

Will Poles vote for the end of democracy?

International media must make clear that these are not fair, democratic elections. The flawed race should be the story at least as much as the race itself.

Latest News

  1. Germany tightens police checks on Czech and Polish border
  2. EU Ombudsman warns of 'new normal' of crisis decision-making
  3. How do you make embarrassing EU documents 'disappear'?
  4. Resurgent Fico hopes for Slovak comeback at Saturday's election
  5. EU and US urge Azerbijan to allow aid access to Armenians
  6. EU warns of Russian 'mass manipulation' as elections loom
  7. Blocking minority of EU states risks derailing asylum overhaul
  8. Will Poles vote for the end of democracy?

Stakeholders' Highlights

  1. International Medical Devices Regulators Forum (IMDRF)Join regulators, industry & healthcare experts at the 24th IMDRF session, September 25-26, Berlin. Register by 20 Sept to join in person or online.
  2. UNOPSUNOPS begins works under EU-funded project to repair schools in Ukraine
  3. Georgia Ministry of Foreign AffairsGeorgia effectively prevents sanctions evasion against Russia – confirm EU, UK, USA
  4. International Medical Devices Regulators Forum (IMDRF)Join regulators & industry experts at the 24th IMDRF session- Berlin September 25-26. Register early for discounted hotel rates
  5. Nordic Council of MinistersGlobal interest in the new Nordic Nutrition Recommendations – here are the speakers for the launch
  6. Nordic Council of Ministers20 June: Launch of the new Nordic Nutrition Recommendations

Stakeholders' Highlights

  1. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  2. ICLEISeven actionable measures to make food procurement in Europe more sustainable
  3. World BankWorld Bank Report Highlights Role of Human Development for a Successful Green Transition in Europe
  4. Nordic Council of MinistersNordic summit to step up the fight against food loss and waste
  5. Nordic Council of MinistersThink-tank: Strengthen co-operation around tech giants’ influence in the Nordics
  6. EFBWWEFBWW calls for the EC to stop exploitation in subcontracting chains

Join EUobserver

Support quality EU news

Join us